Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY-NC-ND 4.0Journal of Vascular Surgery Cases, Innovations and Techniques

Reduction of transjugular intrahepatic portosystemic shunts using the 6-10 mm GORE VIATORR TIPS endoprosthesis with controlled expansion

  1. 1Division of Interventional Radiology, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA

Abstract

This report describes initial clinical experience using the 6- to 10-mm GORE VIATORR transjugular intrahepatic portosystemic shunt (TIPS) Endoprosthesis with Controlled Expansion (W. L. Gore & Associates, Inc.) for reduction of established TIPS. Four patients underwent TIPS reduction for medically refractory hepatic encephalopathy (n=3) or progressive pulmonary hypertension (n=1). A new 6- to 10-mm VIATORR stent was deployed within the existing TIPS and was dilated using a 6 mm balloon in two patients or left without post-placement balloon dilation in two patients. Mean portosystemic gradient increased from 5.0 ± 2.2 to 10.3 ± 1.7 mmHg. All procedures were technically successful without immediate adverse events. All patients with hepatic encephalopathy demonstrated clinical improvement. This method represents a simple and reproducible technique for TIPS reduction, allowing reliable reduction to 6 mm with the option for future stepwise calibration as clinically indicated.

Related

  1. Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition
    Yanting Ye, Zhiyin Huang, Jinhang Gao +1
    Journal of translational internal medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCEurope PMCPMC
  2. Prognostic Value of Serial Alkaline Phosphatase-to-Albumin Ratio for Mortality After Transjugular Intrahepatic Portosystemic Shunt
    Sadik Yavuz, Ezgi Comoglu, Derya Ari +3
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Early Prognostic Value of the Freiburg Index of Post-Transjugular Intrahepatic Portosystemic Shunt Survival in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation
    Yifan Ling, Jiaxin Zhao, Mengni Jing +3
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Clot Out, Flow Back: Large-Bore Aspiration Thrombectomy for Symptomatic Early Transjugular Intrahepatic Portosystemic Shunt (TIPS) Occlusion.
    Renato Abu Hana, Ryosuke Miyauchi, Yusuf Alzoubi +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Reevaluating hypercoagulability in the portal vein and the impact of transjugular intrahepatic portosystemic shunt on platelet activation in cirrhosis
    Viktoria Möller, Anselm Kunstein, Christian Weigel +10
    Research and Practice in Thrombosis and HaemostasisPeer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
BibTeX
@article{cyphers2026reduction,
  title = {{Reduction of transjugular intrahepatic portosystemic shunts using the 6-10 mm GORE VIATORR TIPS endoprosthesis with controlled expansion}},
  author = {Eric D. Cyphers and Samantha S. Chau and Jeffrey Forris Beecham Chick and Matthew Abad-Santos and Ashish R. Vyas and Ryan D. Murray and David S. Shin},
  journal = {Journal of Vascular Surgery Cases, Innovations and Techniques},
  year = {2026},
  month = sep,
  doi = {10.1016/j.jvscit.2026.102539},
  url = {https://doi.org/10.1016/j.jvscit.2026.102539},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Reduction of transjugular intrahepatic portosystemic shunts using the 6-10 mm GORE VIATORR TIPS endoprosthesis with controlled expansion
AU  - Eric D. Cyphers
AU  - Samantha S. Chau
AU  - Jeffrey Forris Beecham Chick
AU  - Matthew Abad-Santos
AU  - Ashish R. Vyas
AU  - Ryan D. Murray
AU  - David S. Shin
PY  - 2026
DA  - 2026/09/29
JO  - Journal of Vascular Surgery Cases, Innovations and Techniques
DO  - 10.1016/j.jvscit.2026.102539
UR  - https://doi.org/10.1016/j.jvscit.2026.102539
AB  - This report describes initial clinical experience using the 6- to 10-mm GORE VIATORR transjugular intrahepatic portosystemic shunt (TIPS) Endoprosthesis with Controlled Expansion (W. L. Gore & Associates, Inc.) for reduction of established TIPS. Four patients underwent TIPS reduction for medically refractory hepatic encephalopathy (n=3) or progressive pulmonary hypertension (n=1). A new 6- to 10-mm VIATORR stent was deployed within the existing TIPS and was dilated using a 6 mm balloon in two patients or left without post-placement balloon dilation in two patients. Mean portosystemic gradient increased from 5.0 ± 2.2 to 10.3 ± 1.7 mmHg. All procedures were technically successful without immediate adverse events. All patients with hepatic encephalopathy demonstrated clinical improvement. This method represents a simple and reproducible technique for TIPS reduction, allowing reliable reduction to 6 mm with the option for future stepwise calibration as clinically indicated.
SN  - 2468-4287
ER  -